🔗 Share this article

Grammy-winning soul vocalist D’Angelo passed away on the fourteenth of October at age 51 after a personal fight with pancreatic cancer.

“The shining star of our family has dimmed his light for us in this life,” his relatives stated. “After a prolonged and brave battle with the disease, we are deeply saddened to announce that D’Angelo, known to his followers around the globe as D’Angelo, has been taken from us.”

D’Angelo left an indelible mark on music with his innovative neo-soul sound and partnerships with high-profile artists.

He released his first record, “Brown Sugar,” in 1995 to instant praise. The album achieved the fourth spot on the R&B charts, went platinum later that year, and received several award nominations.

However, it was his sophomore release, “Voodoo,” in the year 2000 that boosted his music career into the limelight. The album debuted at No. 1 on both the R&B charts and the main album chart. He won two Grammys: Top R&B Record and Outstanding Male Vocal Performance for “Untitled (How Does It Feel).”

The visual for “Untitled (How Does It Feel)” solidified D’Angelo’s standing as a sex symbol, albeit a hesitant one, in the public consciousness. The personal depiction featured the artist, notably bare to his midsection, performing directly into the camera.

D’Angelo retreated from the public eye after releasing Voodoo and publicly struggled with drugs and alcohol. In 2005, he was part of a serious car crash that left him in grave health.

Over ten years later, his last record, “Black Messiah” (2014), confirmed his lasting popularity with another top chart entry on the soul music rankings and a Grammy for Top R&B Record.

Once more, in his own mysterious way, D’Angelo had limited public appearances in the subsequent period.

The musician was announced as a headliner for the 2025 Roots Picnic festival, but his appearance was called off, due to an “unexpected health issue.”

Even though details are sparse about D’Angelo’s health in the weeks before his death, he had apparently been in the hospital for an extended period and in hospice for two weeks.

D’Angelo’s demise is a clear example of the harmful impact of pancreatic cancer, one of the most deadly and hardest to prevent types of the disease, on a brilliant talent whose life was ended too soon.

“We are saddened that he can only provide dear memories with his loved ones, but we are forever thankful for the legacy of deeply emotional songs he has left us,” his kin said.

Pancreatic Malignancy: Lethal and Rarely Preventable

Pancreatic cancer impacts the digestive organ, a small organ that produces the hormone insulin and plays an essential role in digestion, among other functions. The position and dimensions of the organ in the body make it more challenging to identify malignancy.

Even though this cancer makes up only approximately three percent of malignancy cases annually in the United States, it is responsible for seven percent of cancer deaths.

Almost seventy thousand people will be found to have this condition and roughly 52,000 will die of the illness in the year 2025.

“Pancreatic cancer is one of the most lethal diseases, with an fast-growing mass and dismal outcomes. We have few and ineffective therapies, and a smaller window to make a significant difference on the lives of patients,” said a cancer specialist.

Since this disease seldom produces early symptoms, it’s often identified only after the disease is advanced. Even when a patient has symptoms they are often vague and may be confused with a several common illnesses.

“As of yet, there is no effective method to detect pancreatic cancer in the early stages, except for paying attention to physical changes and consulting your doctor if there are unfamiliar signs,” said a health expert.

Frequent indicators of this disease encompass:

• abdominal or lower back pain
• weight loss
• yellowing of skin and eyes
• reduced hunger
• brownish urine
• light-colored or greasy stools
• diarrhea
• excessive hunger or thirst
• feeling sick

At 51 years old, D’Angelo’s death is an exception, as pancreatic cancer is typically found in adults in the 65 to 75 range. However, many cancers, including pancreatic cancer, have become more common among younger people.

“This disease identified before the age of 50 is deemed rare, yet concerningly, clinicians are noticing a growing number of younger individuals affected by this disease,” commented a expert.

Genetic Background Impacts Disease Probability

Without effective screening tools for this malignancy, experts stressed the importance of understanding your relatives’ health background. Certain risk factors, such as tobacco use and obesity also play a role in the development of pancreatic cancer.

African Americans have the greatest occurrence of pancreatic cancer in the U.S. and are most likely to be found to have inoperable cancer.

“The first step toward lowering one’s chance of this condition is understanding personal risk factors. People should examine their genetic background, hereditary factors, and health issues, such as blood sugar disease, chronic pancreatitis, or obesity that may increase their vulnerability,” said a medical professional.

Hereditary elements are linked to as much as ten percent of all this malignancy instances. If a relative in your household has had this disease, you may want to think about DNA analysis.

“For individuals with a relative’s background of this condition or those carrying elevated risk DNA changes, screening may involve sophisticated scans such as magnetic resonance imaging (MRI) or endoscopic ultrasound (EUS) to find early changes in the organ,” he explained.

For those looking to lower their chance, lifestyle changes may have an effect. The best action you can take to lower your risk of pancreatic cancer is to stop tobacco use, and if you don’t smoke, stay away altogether.

Heavy drinking is linked to pancreas inflammation, a contributing element for this malignancy, so limiting or avoiding drinks may help reduce your risk.

Controlling your weight or losing weight may also aid decrease your susceptibility. People with excess weight are twenty percent more prone to develop pancreatic cancer. This malignancy also occurs more often in people with diabetes, and reducing weight can also lower the risk of type 2 diabetes.

Despite pancreatic cancer’s poor prognosis, there is reason for optimism.

“We are making progress with therapies and newer combination chemotherapy. There are emerging targeted therapies that already are making an impact,” remarked a expert.

For many individuals, however, education about this uncommon but {dev